Cargando…

Effect of Ivabradine on Left Ventricular Diastolic Function of Patients With Preserved Ejection Fraction　― Results of the IVA-PEF Study ―

Background: The association between heart rate (HR) reductions caused by ivabradine and left ventricular (LV) diastolic function in heart failure with preserved ejection fraction (HFpEF) remains uncertain because of off-label use. Thus, the present study investigated the effect of HR reductions by i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Hidekazu, Yamauchi, Yuki, Imanishi, Junichi, Hatani, Yutaka, Odajima, Susumu, Okamoto, Hiroshi, Hayashi, Takatoshi, Hirata, Ken-ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535126/ https://www.ncbi.nlm.nih.gov/pubmed/36304432 http://dx.doi.org/10.1253/circrep.CR-22-0067

Ejemplares similares

Mid-term effect of balloon aortic valvuloplasty on mitral regurgitation in aortic stenosis
por: Masaki, Ryota, et al.
Publicado: (2020)

The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction. A Doppler-Echocardiographic study
por: Cacciapuoti, Federico, et al.
Publicado: (2017)

Three Cases of Caseous Calcification of the Mitral Annulus Resulting in Spontaneous Fistulation
por: Fujiwara, Momo, et al.
Publicado: (2022)

Aetiology of chronic heart failure in patients from a super‐aged society: the KUNIUMI registry chronic cohort
por: Fujimoto, Wataru, et al.
Publicado: (2022)

Prognostic Impact of the Clinical Frailty Scale After Balloon Aortic Valvuloplasty
por: Hamana, Tomoyo, et al.
Publicado: (2020)

Importance of Optimized Guideline-Based Therapy for Preventing Rehospitalization of Chronic Heart Failure Patients　― From the KUNIUMI Acute Cohort ―
por: Odajima, Susumu, et al.
Publicado: (2021)

Association of congestion with worsening renal function in acute decompensated heart failure according to age
por: Odajima, Susumu, et al.
Publicado: (2022)

Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020)

An unusual triphasic transmitral flow: a special case of ‘mid-diastolic mitral regurgitation’ due to acute aortic regurgitation
por: Odajima, Susumu, et al.
Publicado: (2021)

Effect of Ivabradine on Endothelial Function in Diastolic and Right Heart Failure Patients
por: Orea-Tejeda, Arturo, et al.
Publicado: (2013)

Treatment of Fulminant Giant Cell Myocarditis Associated with Polymyositis Using a Left Ventricular Assist Device and Subsequent Corticosteroid and Immunosuppressive Therapy Leading to Remission
por: Ooka, Junichi, et al.
Publicado: (2017)

Ivabradine Ameliorates Cardiac Diastolic Dysfunction in Diabetic Mice Independent of Heart Rate Reduction
por: Xie, Hao, et al.
Publicado: (2021)

Comparison Between Ivabradine and Low-Dose Digoxin in the Therapy of Diastolic Heart Failure with Preserved Left Ventricular Systolic Function
por: Cocco, Giuseppe, et al.
Publicado: (2013)

Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction
por: Parasuraman, Sathish K., et al.
Publicado: (2019)

Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure
por: Chowdhury, Shahryar M., et al.
Publicado: (2022)

Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
por: Lee, Ying‐Hsiang, et al.
Publicado: (2021)

Effect of ivabradine on ventricular arrhythmias in heart failure patients with reduced ejection fraction
por: Pay, Levent, et al.
Publicado: (2023)

Optimal Cut-Off of Tricuspid Regurgitation Velocity According to the New Definition of Pulmonary Hypertension　― Its Use in Predicting Pulmonary Hypertension ―
por: Sumimoto, Keiko, et al.
Publicado: (2020)

The Road to Bring FDCA and PEF to the Market
por: de Jong, Ed, et al.
Publicado: (2022)

Echocardiographic evaluation of changes in diastolic dysfunction after CABG surgery, effect of novel therapy with Ivabradine
por: Panayotova, D, et al.
Publicado: (2013)

Pulmonary Hypertension in Elderly Patients with Diastolic Dysfunction and Preserved Ejection Fraction
por: Afshar, Majid, et al.
Publicado: (2012)

Impact of Updated Guidelines on Diastolic Dysfunction in Patients with Preserved Ejection Fraction
por: Yoon, Hyun Ju
Publicado: (2021)

Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
por: Wenzel, Jan-Per, et al.
Publicado: (2021)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
por: Teuber, James P., et al.
Publicado: (2022)

Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation
por: Lin, Yu‐Sheng, et al.
Publicado: (2022)

Diastolic index as a short-term prognostic factor in heart failure with preserved ejection fraction
por: Hoshida, Shiro, et al.
Publicado: (2020)

Ivabradine Ameliorates Cardiac Function in Heart Failure with Preserved and Reduced Ejection Fraction via Upregulation of miR-133a
por: Shao, Shuai, et al.
Publicado: (2021)

Multiple coordinated cellular dynamics mediate CA1 map plasticity
por: Mizuta, Kotaro, et al.
Publicado: (2021)

Myocardial strain for heart failure with preserved ejection fraction but without diastolic dysfunction
por: Park, Jin Joo, et al.
Publicado: (2022)

A Case of Postpartum Pulmonary Edema With Preserved Ejection Fraction and Diastolic Capacity
por: Tanabe, Shohei, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction
por: Krittayaphong, Rungroj, et al.
Publicado: (2019)

Ivabradine in sepsis
por: Nair, Abhijit S, et al.
Publicado: (2013)

A Perspective on PEF Synthesis, Properties, and End-Life
por: Loos, Katja, et al.
Publicado: (2020)

The application of PEF technology in food processing and human nutrition
por: Nowosad, Karolina, et al.
Publicado: (2020)

Safety of Intravenous Autologous Bone Marrow-Derived Mesenchymal Cell Transplantation in 5 Patients With Reduced Left Ventricular Ejection Fraction
por: Sato, Yukihito, et al.
Publicado: (2021)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

Prognostic significance of diastolic blood pressure in patients with heart failure with preserved ejection fraction
por: Fuchida, Aya, et al.
Publicado: (2021)

Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
por: Dal Canto, Elisa, et al.
Publicado: (2020)

Diet modification reverses diastolic dysfunction in rats with heart failure and preserved ejection fraction
por: Kim, Myung Yoon, et al.
Publicado: (2023)

Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co‐treatment in pigs with acute ischemic heart failure
por: Rønning, Leif, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1t8cr49j4hkj0t1hh5kek8mphr